EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of EC ‐ EXOs ‐Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss

Jiaojiao Wang, Zhaokai Zhou, Wenjie Chen, Yun Chen, Qiyue Zheng, Yajun Chen, Zhengxiao Ouyang iD, Ran Xu, Qiong Lu iD

Cell Proliferation · 2025-12 · 58 (12)

DOI: 10.1111/cpr.70066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 13.06.2025. Verfasst von Jiaojiao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, CD47 Antigen, Cell Differentiation, Osteoporosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Changsha City, Hunan Provincial Development and Reform Commission of Innovative Research Program, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the continuous increase of the elderly population and the deepening of population ageing in China, osteoporosis has gradually become one of the significant public health problems. Elucidating the pathophysiological mechanisms that induce osteoporosis and identifying more effective therapeutic targets is of great clinical significance. In this study, in vitro experiments demonstrated that endothelial cell exosomes (EC‐EXOs) promoted osteogenic and inhibited adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Aged and ovariectomy (OVX)‐induced osteoporosis mice models injected with EC‐EXOs confirmed that EC‐EXOs delayed bone loss. Proteomic analysis revealed a key protein regulating the differentiation of BMSCs. Expression of THBS3 was significantly higher in EC‐EXOs than in Human microvascular endothelial cells (HMEC‐1). In vitro and in vivo experiments further validated that THBS3 promoted BMSCs' osteogenic differentiation, inhibited their adipogenic differentiation, and retarded bone loss. Computational biology analysis found that CD47 is a downstream target and potentially functional receptor in BMSCs that bind to THBS3. THBS3 treatment of BMSCs down‐regulated the expression of CD47 in in vitro experiments. The aged/OVX models further confirmed that EC‐EXOs can regulate the differentiation of BMSCs and delay the process of bone loss via the THBS3–CD47 axis. CD47 antibody may be a potential therapeutic agent for treating ageing‐associated bone loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsCD47 AntigenCell DifferentiationOsteoporosisEndothelial CellsThrombospondinsAnimalsHumansMiceOsteogenesisFemaleAdipogenesisMice, Inbred C57BLOvariectomyDisease Models, Animal

Stichwörter der Autor:innen

CD47 antibodyageingbone marrow mesenchymal stem cellsosteogenic differentiationosteoporosisthrombospondin‐3vascular endothelial cell exosomes

Substanzen

CD47 AntigenThrombospondins

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, People's Republic of China.
  • Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.

ORCID-Profile: Zhengxiao Ouyang, Qiong Lu

Förderung

  • Natural Science Foundation of Changsha City
  • Hunan Provincial Development and Reform Commission of Innovative Research Program
  • Natural Science Foundation of Hunan Province
  • Hunan Innovative Province Construction Special Project
  • Hunan Provincial Department of Finance Grant

Zitieren

APA

Wang, J., Zhou, Z., Chen, W., Chen, Y., Zheng, Q., Chen, Y., Ouyang, Z., Xu, R., & Lu, Q. (2025). Mechanism of EC ‐ EXOs ‐Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss. Cell Proliferation, 58(12). https://doi.org/10.1111/cpr.70066

Vancouver

Wang J, Zhou Z, Chen W, Chen Y, Zheng Q, Chen Y, et al. Mechanism of EC ‐ EXOs ‐Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss. Cell Proliferation. 2025;58(12). doi:10.1111/cpr.70066

BibTeX
@article{Wang2025,
  author = {Wang, Jiaojiao and Zhou, Zhaokai and Chen, Wenjie and Chen, Yun and Zheng, Qiyue and Chen, Yajun and Ouyang, Zhengxiao and Xu, Ran and Lu, Qiong},
  title = {Mechanism of EC ‐ EXOs ‐Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss},
  journal = {Cell Proliferation},
  year = {2025},
  volume = {58},
  number = {12},
  doi = {10.1111/cpr.70066}
}
Kostenlos starten →